Clinical trial
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4 (OPTIM)
The primary objective is to develop and validate a tool towards patients with chronic hepatitis C genotype 1 and 4 to allow optimize treatment.
| Category | Value |
|---|---|
| Study start date | 2013-06-18 |